logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
20/03/2026
Eric Life Sciences Limited: Generic drug, Semaglutide, will be listed in India on March 21, 2026.
Latest
4 m ago
Xiaopeng Motors Chairman and CEO He Xiaopeng stated that since the mass production of the Turing chip in the third quarter of 2025, the cumulative shipment of chips has exceeded 200,000 pieces. The company expects that starting from the second quarter of this year, all models (including the Max version) will switch to the self-developed Turing chip, and the annual shipment target is close to 1 million pieces. It is expected to become the top shipper of AI chips on the Chinese large-scaled calculation side. He Xiaopeng also stated that Volkswagen is the first customer to use the Turing chip and the second-generation VLA chips. The company will open the Turing chip and intelligent overall solutions to more automotive companies, AI enterprises, and Tier 1 suppliers.
4 m ago
Spanish Prime Minister Sanchez: We also agree to temporarily freeze rental prices through a second legislation.
5 m ago
On March 20, Ling Ji, Vice Minister of the Ministry of Commerce and Deputy Representative for International Trade Negotiations, met with Lin Yiming, Executive Vice President of Danish pharmaceutical company Novo Nordisk, to exchange views on the operation of the company in China and the opportunities for open development in China. Ling Ji stated that in recent years, China's technology innovation capability has rapidly improved and the scale of the pharmaceutical and health industry has continued to expand. China has become a global innovation source with new productive forces promoting high-quality economic development. He hopes Novo Nordisk will continue to deepen its presence in the Chinese market and contribute to building a healthy China. Lin Yiming expressed that Novo Nordisk is optimistic about China's huge market potential and highly appreciates the Chinese government's continuous efforts to optimize the business environment and strengthen intellectual property protection. They are willing to further increase investment in China, expand localization production and research and development, and support the vigorous development of the Chinese pharmaceutical and health industry (Ministry of Commerce).
5 m ago
China Rare Earth Group: Promoting the transformation of traditional rare earth manufacturing into high-end intelligent manufacturing and green intelligent manufacturing.
6 m ago
Deputy Minister of Commerce Ling Ji meets with Executive Vice President Lin Yiming of Danish company Novo Nordisk.
See all latestmore
logo
Contact US
qr
+852 - 60190728
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.